Total flavonoids in Premna fulva Craib alleviates brain neurological impairment and influences Nrf2 and HO-1 expressions in rats with ischemia-reperfusion

被引:7
作者
Qin, Hui [1 ]
Fu, Youxue [1 ]
Jiang, Ying [1 ]
Tian, Zhao [2 ]
Zhang, Yongquan [1 ]
Tan, Wenlan [1 ]
Liang, Mingkun [1 ]
Wen, Haicheng [3 ]
Fang, Gang [4 ]
机构
[1] Guangxi Univ Tradit Chinese Med, Rui Kang Hosp, Dept Neurosurg, Nanning 530011, Guangxi, Peoples R China
[2] GuangXi Univ Chinese Med, Dept Neurol, Nanning 530001, Guangxi, Peoples R China
[3] Guangxi Univ Chinese Med, Zhuang Med Coll, Dept Neurol, Nanning 530001, Guangxi, Peoples R China
[4] GuangXi Univ Chinese Med, Guangxi Key Lab Appl Fundamental Res Zhuang Med, Nanning 530001, Guangxi, Peoples R China
关键词
Total flavonoids in Premna fulva Craib; Ischemia-Reperfusion; nuclear factor E2-related factor 2; Heme oxygenase 1; OXIDATIVE STRESS; IN-VITRO; STROKE; INFLAMMATION; PARAMETERS; MODULATION; MECHANISMS; PROTECTS; NEURONS; OXYGEN;
D O I
10.14715/cmb/2022.68.6.25
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Total flavonoids in Premna fulva Craib (TFPFC) are a kind of flavonoid compound synthesized via photosynthesis extracted from Premna fulva Craib, which possess a strong anti-oxidative effect. Cerebral Ischemia-Reperfusion refers to the body's damage mainly caused by oxidative stress. This study aims to investigate the alleviating effect of TFPFC on brain neurological impairment and its influences on Nuclear factor E2-related factor 2 (Nrf2) and heme oxygenase 1 (HO-1) expressions in rats with Ischemia-Reperfusion. The rat model of Ischemia-Reperfusion was established, and rats were treated with TFPFC or normal saline. At 24 h after reperfusion, the neurological score, volume of cerebral infarction and cerebral water content were analyzed in different groups. The influences of TFPFC treatment on the proliferative activity and apoptosis of oxygen and glucose deprivation/reoxygenation (OGD/R) neural stem cells were detected via methyl thiazolyl tetrazolium (MTT) assay and flow cytometry. Moreover, the malondialdehyde (MDA) level and superoxide dismutase (SOD) activity were measured to evaluate the oxidative stress effect. The influences of TFPFC treatment on the protein and messenger ribonucleic acid (mRNA) expressions of Nrf2 and HO-1 were analyzed using reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting. The TFPFC treatment alleviated the neurological impairment in rats after Ischemia-Reperfusion and reduced the volume of cerebral infarction and cerebral edema status in rats with Ischemia-Reperfusion. TFPFC increased the proliferative activity of OGD/R neural stem cells and decreased damage and apoptosis. In addition, the TFPFC treatment reduced the MDA level, improved the SOD activity, and up-regulated the protein and mRNA expressions of Nrf2 and HO-1. The TFPFC treatment may improve oxidative damage and protect the nervous system through the up-regulation of expressions of transcription factors Nrf2 and HO-1. Copyright: (c) 2022 by the C.M.B. Association. All rights reserved.
引用
收藏
页码:155 / 160
页数:6
相关论文
共 50 条
  • [41] Therapeutic Role of Chinese Medicine Targeting Nrf2/HO-1 Signaling Pathway in Myocardial Ischemia/Reperfusion Injury
    Liu, Chang-xing
    Guo, Xin-yi
    Zhou, Ya-bin
    Wang, He
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2024, 30 (10) : 949 - 960
  • [42] Normobaric hyperoxia plays a protective role against renal ischemia-reperfusion injury by activating the Nrf2/HO-1 signaling pathway
    Pei, Jun
    Cai, Shuyu
    Song, Shang
    Xu, Yuangao
    Feng, Mei
    Luo, Guangheng
    Wang, Yuanlin
    Sun, Fa
    Shi, Hua
    Xu, Shuxiong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 532 (01) : 151 - 158
  • [43] Activation of Nrf2/HO-1 Pathway by Glycogen Synthase Kinase-3β Inhibition Attenuates Renal Ischemia/Reperfusion Injury in Diabetic Rats
    Shen, Xiaohua
    Hu, Bo
    Xu, Guangtao
    Chen, Fengjuan
    Ma, Ruifen
    Zhang, Nenghua
    Liu, Jie
    Ma, Xiaoqin
    Zhu, Jia
    Wu, Yuhong
    Shen, Ruilin
    KIDNEY & BLOOD PRESSURE RESEARCH, 2017, 42 (02) : 369 - 378
  • [44] Isoliquiritigenin alleviates myocardial ischemia-reperfusion injury by regulating the Nrf2/HO-1/SLC7a11/GPX4 axis in mice
    Yao, Deshan
    Bao, Liuxiang
    Wang, Sichuan
    Tan, Meng
    Xu, Yuanyuan
    Wu, Tianxu
    Zhang, Zhengang
    Gong, Kaizheng
    FREE RADICAL BIOLOGY AND MEDICINE, 2024, 221 : 1 - 12
  • [45] Pint aggravates renal injury induced by ischemia and reperfusion in rats via Nrf2/HO-1 mediated endoplasmic reticulum stress
    Yu, Honglin
    Jiang, Guanjun
    Hu, Wei
    Xu, Changgeng
    ACTA CIRURGICA BRASILEIRA, 2022, 37 (01)
  • [46] Simvastatin attenuates renal ischemia/reperfusion injury from oxidative stress via targeting Nrf2/HO-1 pathway
    Zhang, Yu
    Rong, Shu
    Feng, Yi
    Zhao, Liqun
    Hong, Jiang
    Wang, Ruilan
    Yuan, Weijie
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (05) : 4460 - 4466
  • [47] Hypothermic oxygenated perfusion ameliorates -ischemia-reperfusion injury of fatty liver in mice via Brg1/Nrf2/HO-1 axis
    Wang, Shengjie
    Zeng, Xianpeng
    Yang, Yunying
    Li, Shiyi
    Wang, Yanfeng
    Ye, Qifa
    Fan, Xiaoli
    ARTIFICIAL ORGANS, 2022, 46 (02) : 229 - 238
  • [48] DADLE improves hepatic ischemia/reperfusion injury in mice via activation of the Nrf2/HO-1 pathway
    Zhou, Yi
    Zhang, Jing
    Lei, Biao
    Liang, Wenjin
    Gong, Jianhua
    Zhao, Chuanxiang
    Yu, Jidong
    Li, Xuan
    Tang, Bo
    Yuan, Shengguang
    MOLECULAR MEDICINE REPORTS, 2017, 16 (05) : 6214 - 6221
  • [49] Edaravone dexborneol protects cerebral ischemia reperfusion injury through activating Nrf2/HO-1 signaling pathway in mice
    Xu, Lili
    Gao, Yaran
    Hu, Ming
    Dong, Yanhong
    Xu, Jing
    Zhang, Jiawei
    Lv, Peiyuan
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 (05) : 790 - 800
  • [50] Isorhapontigenin ameliorates cerebral ischemia/reperfusion injury via modulating Kinase Cε/Nrf2/HO-1 signaling pathway
    Xue, Zhe
    Zhao, Kai
    Sun, Zhenghui
    Wu, Chen
    Yu, Bowen
    Kong, Dongsheng
    Xu, Bainan
    BRAIN AND BEHAVIOR, 2021, 11 (07):